AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza…
Drug Manufacturers - General
GB, Cambridge [HQ]
AZN/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32,804.00 | 33,269.00 | 33,591.00 | 27,973.00 | 25,711.00 | 26,095.00 | 24,708.00 | 23,002.00 | 22,465.00 | 22,090.00 | 24,384.00 | 26,617.00 | 37,417.00 | 44,351.00 | 45,811.00 | |
|
EPS
|
5.19 | 5.60 | 7.33 | 4.99 | 2.04 | 0.98 | 2.23 | 2.77 | 2.37 | 1.70 | 1.03 | 2.44 | 0.08 | 2.12 | 3.84 | |
| Diluted in mil. | 5.19 | 5.57 | 7.30 | 4.93 | 2.04 | 0.98 | 2.23 | 2.76 | 2.37 | 1.70 | 1.03 | 2.44 | 0.08 | 2.11 | 3.81 | |
|
Profit
|
27,029.00 | 26,880.00 | 27,565.00 | 22,580.00 | 20,450.00 | 20,253.00 | 20,062.00 | 18,876.00 | 18,147.00 | 17,154.00 | 19,463.00 | 21,318.00 | 24,980.00 | 31,960.00 | 37,543.00 | |
| Gross Margin | 82.40 | 80.80 | 82.06 | 80.72 | 79.54 | 77.61 | 81.20 | 82.06 | 80.78 | 77.66 | 79.82 | 80.09 | 66.76 | 72.06 | 81.95 | |
| Pre Tax | 10,807.00 | 10,977.00 | 12,367.00 | 7,718.00 | 3,267.00 | 1,246.00 | 3,069.00 | 3,552.00 | 2,227.00 | 1,993.00 | 1,548.00 | 3,916.00 | -265.00 | 2,501.00 | 6,899.00 | |
| Profit Margin | 32.94 | 32.99 | 36.82 | 27.59 | 12.71 | 4.77 | 12.42 | 15.44 | 9.91 | 9.02 | 6.35 | 14.71 | -0.71 | 5.64 | 15.06 | |
| ETR | 30.19 | 26.38 | 19.01 | 18.02 | 21.30 | 0.88 | 7.92 | 4.11 | -28.78 | -2.86 | 20.74 | 19.71 | 143.40 | -31.67 | 13.60 | |
| Net | 7,521.00 | 8,053.00 | 9,983.00 | 6,297.00 | 2,556.00 | 1,233.00 | 2,825.00 | 3,499.00 | 3,001.00 | 2,155.00 | 1,335.00 | 3,196.00 | 112.00 | 3,288.00 | 5,955.00 | |
| Profit Margin | 22.93 | 24.21 | 29.72 | 22.51 | 9.94 | 4.73 | 11.43 | 15.21 | 13.36 | 9.76 | 5.47 | 12.01 | 0.30 | 7.41 | 13.00 | |
| EBITDA | 14,092.00 | 14,751.00 | 14,414.00 | 11,194.00 | 8,345.00 | 5,491.00 | 6,996.00 | 7,293.00 | 6,771.00 | 7,165.00 | 7,016.00 | 8,371.00 | 7,565.00 | 9,327.00 | 13,911.00 | |
| EBITDA Margin | 42.96 | 44.34 | 42.91 | 40.02 | 32.46 | 21.04 | 28.31 | 31.71 | 30.14 | 32.44 | 28.77 | 31.45 | 20.22 | 21.03 | 30.37 | |
| Operating Income | 11,543.00 | 11,494.00 | 12,795.00 | 8,148.00 | 3,712.00 | 2,137.00 | 4,114.00 | 4,902.00 | 3,677.00 | 3,387.00 | 2,924.00 | 5,162.00 | 1,056.00 | 3,757.00 | 8,193.00 | |
| Operating Margin | 35.19 | 34.55 | 38.09 | 29.13 | 14.44 | 8.19 | 16.65 | 21.31 | 16.37 | 15.33 | 11.99 | 19.39 | 2.82 | 8.47 | 17.88 | |
| Interest Income | 462.00 | 516.00 | 552.00 | 528.00 | 50.00 | 78.00 | 46.00 | 67.00 | 113.00 | 138.00 | 172.00 | 87.00 | 43.00 | 95.00 | 301.00 | |
| Loss | -21,261.00 | -21,775.00 | -22,279.00 | -19,825.00 | -21,999.00 | -23,958.00 | -20,594.00 | -18,100.00 | -18,788.00 | -18,703.00 | -21,186.00 | -21,455.00 | -36,361.00 | -40,594.00 | -37,089.00 | |
| Cost of Revenue | -5,775.00 | -6,389.00 | -6,026.00 | -5,393.00 | -5,261.00 | -5,842.00 | -4,646.00 | -4,126.00 | -4,318.00 | -4,936.00 | -4,921.00 | -5,299.00 | -12,437.00 | -12,391.00 | -8,268.00 | |
|
Operating Expenses
|
-15,486.00 | -15,386.00 | -16,253.00 | -14,432.00 | -16,738.00 | -18,116.00 | -15,948.00 | -13,974.00 | -14,470.00 | -13,767.00 | -16,265.00 | -16,156.00 | -23,924.00 | -28,203.00 | -28,821.00 | |
| R&D | -4,409.00 | -5,318.00 | -5,523.00 | -5,243.00 | -4,821.00 | -5,579.00 | -5,997.00 | -5,890.00 | -5,757.00 | -5,932.00 | -5,958.00 | -5,991.00 | -9,736.00 | -9,762.00 | -10,935.00 | |
| G&A | -11,332.00 | -10,445.00 | -11,161.00 | -9,839.00 | -12,206.00 | -13,000.00 | -11,112.00 | -9,413.00 | -10,233.00 | - - | -11,682.00 | - - | - - | - - | - - | |
| SG&A | -11,630.00 | -10,780.00 | -11,507.00 | -10,159.00 | -12,512.00 | -13,324.00 | -11,451.00 | -9,739.00 | -10,543.00 | -10,362.00 | -11,848.00 | -11,693.00 | -15,680.00 | -18,955.00 | -18,222.00 | |
| S&M | -298.00 | -335.00 | -11,507.00 | -10,159.00 | -12,512.00 | -13,324.00 | -11,451.00 | -9,739.00 | -10,543.00 | -10,362.00 | -11,848.00 | -11,693.00 | -15,680.00 | -18,955.00 | -18,222.00 | |
| Depreciation and Amortization | -2,087.00 | -2,741.00 | -2,550.00 | -2,518.00 | -4,583.00 | -3,282.00 | -2,852.00 | -2,357.00 | -3,036.00 | -3,753.00 | -3,762.00 | -3,149.00 | -6,530.00 | -5,480.00 | -4,934.00 | |
| Interest Expenses | -1,198.00 | -1,033.00 | -980.00 | -958.00 | -495.00 | -963.00 | -1,075.00 | -1,384.00 | -1,508.00 | -1,419.00 | -1,432.00 | -1,306.00 | -1,300.00 | -1,346.00 | -1,589.00 | |
| Other Expenses | -736.00 | -195.00 | -1,832.00 | -430.00 | -412.00 | -859.00 | -63.00 | -20.00 | -65.00 | -483.00 | -1,376.00 | -1,246.00 | -1,321.00 | -1,256.00 | -1,294.00 | |
|
WA Shares Outstanding
|
1,448.00 | 1,438.00 | 1,361.00 | 1,261.00 | 1,252.00 | 1,262.00 | 1,264.00 | 1,265.00 | 1,266.00 | 1,267.00 | 1,301.00 | 1,312.00 | 1,418.00 | 1,548.00 | 1,549.00 | |
| Diluted | 1,450.00 | 1,446.00 | 1,367.00 | 1,264.00 | 1,254.00 | 1,264.00 | 1,265.00 | 1,266.00 | 1,267.00 | 1,267.00 | 1,301.00 | 1,313.00 | 1,427.00 | 1,560.00 | 1,562.00 |